Drug Discovery – Drug Development Pipeline
Using its proprietary platforms and other behavioral expertise, PsychoGenics has created a diverse pipeline of drug candidates for itself and its partners, Eli Lilly, Roche and Sunovion (formerly Sepracor) addressing major CNS disorders such as ADHD, cognitive impairment, depression, pain, and psychosis/schizophrenia.
PsychoGenics is actively seeking partners for its internal programs.
